These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2555353)

  • 1. A synthetic linear decapeptide binds to the atrial natriuretic peptide receptors and demonstrates cyclase activation and vasorelaxant activity.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; Mehta PP; McMahon EG; Palomo M; Schuh J; Blehm D
    J Biol Chem; 1989 Dec; 264(34):20309-13. PubMed ID: 2555353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A linear analog of atrial natriuretic peptide (ANP) discriminates guanylate cyclase-coupled ANP receptors from non-coupled receptors.
    Olins GM; Patton DR; Bovy PR; Mehta PP
    J Biol Chem; 1988 Aug; 263(22):10989-93. PubMed ID: 2899082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps).
    Schweitz H; Vigne P; Moinier D; Frelin C; Lazdunski M
    J Biol Chem; 1992 Jul; 267(20):13928-32. PubMed ID: 1352773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
    Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
    J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of structural requirements for analogues of atrial natriuretic peptide (ANP) to discriminate between ANP receptor subtypes.
    Bovy PR; O'Neal JM; Olins GM; Patton DR
    J Med Chem; 1989 Apr; 32(4):869-74. PubMed ID: 2564895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells.
    Anand-Srivastava MB
    Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat.
    St-Louis J; Schiffrin EL
    Can J Physiol Pharmacol; 1988 Jul; 66(7):951-6. PubMed ID: 2850846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the C-terminal region of rat brain natriuretic peptide in receptor selectivity.
    Shimekake Y; Kawabata T; Nakamura M; Nagata K
    FEBS Lett; 1992 Sep; 309(2):185-9. PubMed ID: 1324196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of metabolically stable atrial natriuretic factor analogs. Amino- and carboxy-terminal stabilization.
    Berman JM; Chen TM; Sargent R; Buck SH; Shea P; Heminger EF; Broersma RJ
    FEBS Lett; 1988 Sep; 237(1-2):76-80. PubMed ID: 2844589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
    Imura R; Sano T; Goto J; Yamada K; Matsuda Y
    Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear alpha-human atrial natriuretic peptide analogs display receptor binding activity and inhibit alpha-hANP-induced cGMP accumulation.
    Kitajima Y; Minamitake Y; Furuya M; Takehisa M; Katayama T; Tanaka S
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1295-301. PubMed ID: 2556125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
    Mouawad R; Li Y; Anand-Srivastava MB
    Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation.
    von Geldern TW; Budzik GP; Dillon TP
    Biochem Biophys Res Commun; 1992 Jun; 185(2):734-9. PubMed ID: 1319147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity profiles of atrial natriuretic peptide (ANP) analogs with reduced ring size.
    Schiller PW; Bellini F; Dionne G; Maziak LA; Garcia R; DeLéan A; Cantin M
    Biochem Biophys Res Commun; 1986 Jul; 138(2):880-6. PubMed ID: 2943281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide in bovine corpus luteum.
    Vollmar AM; Mytzka C; Arendt RM; Schulz R
    Endocrinology; 1988 Aug; 123(2):762-7. PubMed ID: 2899502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
    Kumar R; Cartledge WA; Lincoln TM; Pandey KN
    Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
    Bellemann P; Neuser D
    J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes.
    Budzik GP; Firestone SL; Bush EN; Connolly PJ; Rockway TW; Sarin VK; Holleman WH
    Biochem Biophys Res Commun; 1987 Apr; 144(1):422-31. PubMed ID: 3034249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of hydrophobic residues in alpha-human atrial natriuretic peptide (alpha-hANP) for vasorelaxant activity.
    Minamitake Y; Kitajima Y; Furuya M; Yoshida M; Tanaka S
    Biochem Biophys Res Commun; 1990 Nov; 172(3):971-8. PubMed ID: 2173923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
    Itoh H; Pratt RE; Dzau VJ
    J Clin Invest; 1990 Nov; 86(5):1690-7. PubMed ID: 2173726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.